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ABSTRACT 
Biaryl bonds are a common motif found in biologically active compounds and 
the majority of marketed pharmaceuticals. The contemporary methods used to 
synthesize these biaryl bonds, albeit high yielding, are not economical because they 
require several prefunctionalization steps that create a high volume of waste and 
byproducts. Cross-dehydrogenative coupling (CDC) is the future of green coupling 
techniques, since it requires no prefunctionalization of substrates and can obtain high 
yields with a relatively low catalyst loading. Herein, we report on advances being 
made in the field of CDC, and our own efforts to achieve cross coupling utilizing 
benzimidazole moieties.  
The first manuscript, “Aryl-Aryl Bond Formation via CDC Reactions” is a 
comprehensive review of the latest and most notable achievements being made in the 
area of biaryl CDC reactions. The manuscript focuses on cross-dehydrogenative 
coupling as a green method that can be used to create aryl-aryl bonds on a vast array 
of substrates. Several different classes of CDC reaction conditions were examined 
including Pd, Rh, Ru, Cu, and Fe-based catalytic systems.    
The second manuscript, “Intramolecular Arylation of Benzimidazoles via 
Pd(II)/Cu(I) catalyzed Cross-Dehydrogenative Coupling” describes research done on 
the intramolecular biaryl CDC reaction between simple arenes and benzimidazoles. 
This novel reaction is carried out on N-benzylbenzimidazoles that upon cyclization 
forms a fused polycyclic system. The reaction conditions were optimized and tested on 
a large library of substrates, and the mechanism was probed using kinetic isotope 
studies and varied reaction conditions to suggest a unique Pd(II)/Cu(I) catalytic cycle. 
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PREFACE 
The following work is presented in manuscript format according to the 
guidelines presented by the University of Rhode Island Graduate School. The thesis 
will consist of two manuscripts that are currently in the process of publication. 
Manuscript 1 entitled, “Aryl-Aryl Coupling via CDC Reactions” is being 
published in 2014 as a chapter in the book “Carbon-carbon Bond Formations via 
Cross-Dehydrogenative Coupling of C-H Bonds” by the Royal Society of Chemistry 
and edited by C. J. Li.  
Manuscript 2 entitled, “Intramolecular Arylation of Benzimidazoles via 
Pd(II)/Cu(I) catalyzed Cross-Dehydrogenative Coupling” has been presented as a 
poster at the 252nd ACS National Meeting and Exposition in Philadelphia (August 
2012) and will be submitted to Tetrahedron Letters for publication in October 2013.   
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INTRODUCTION 
 
 The formation of aryl-aryl bonds is one of the most fundamental reactions in 
organic synthesis. Biaryls are contained in many bioactive therapeutic agents 
including, anti-inflammatory, antifungal, antiviral, and anticancer agents,1 making it a 
highly desirable motif to the pharmaceutical industry.2 Also, many useful synthetic 
materials contain biaryls, including dyes, semiconductors, agrochemicals, and many 
types of ligands.3 With such a vast scope of uses, the ability to easily synthesize these 
aryl-aryl functionalities on nearly any compound is a demand that researchers have 
been trying to improve on over the past century.  
 One of first published examples of aryl-aryl bond formation was the Ullmann 
reaction originally published in 1901.4 The Ullmann reaction was able to synthesize 
symmetric biaryls by heating two equivalents of an aryl-halide and one equivalent of 
copper at very high temperatures. This reaction was a great success; however, it 
utilized a stoichiometric amount of copper metal and had limited success with non-
symmetric coupling. Despite these shortcomings, aryl-aryl bonds continued to be 
made mainly using copper Ullmann type conditions until the 1970s.3 
 Only in the past few decades has the use of other transition metals like Pd, Pt, 
Rh, and Ru taken a prominent role in aryl-aryl bond formation. These metals can be 
used in catalytic amounts and can catalyze cross coupling as well as homocoupling of 
arenes. The use of Pd especially has become common since the Kumada cross 
coupling conditions on olefins were shown to work with a Pd catalyst in 1975 by 
Murahashi.5 Palladium has since been found to work very well in aryl-aryl bond 
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formation because of its ability to tolerate a wide variety of organometallic 
nucleophiles including tin, silica, boron, lead, and magnesium species.3 Today, most 
of the contemporary biaryl coupling techniques utilize catalytic amounts of Pd to form 
aryl-aryl bonds. Some of the more common ones are highlighted in (Scheme 1).   
 
    Scheme 1- Conventional Biaryl Coupling Techniques 
 
 All of the Pd catalyzed aryl coupling techniques above are theorized to operate 
under a similar mechanistic scheme. (Scheme 2) There are three main steps to the 
catalytic cycle, the first of which is oxidative addition of the Pd(0) catalyst into the C-
halogen bond of an aryl-halide. As the Pd is inserting it forms two new covalent bonds 
and is oxidized to a Pd(II) complex with one aryl group and a halide. This oxidative 
addition step is often the rate-limiting step of the catalytic cycle.6 Next, 
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transmetalation occurs, and a second aryl group is swapped for the halide on the Pd(II) 
complex from another aryl-metal species, such as B, Sn, or Zn. This step loads both 
aryl groups on the Pd without changing the oxidation state of either metal during 
transmetalation. 
 
Scheme 2- Catalytic Mechanism for Conventional Coupling Techniques 
 
 
 The final step is reductive elimination of the two aryl groups from the Pd(II) 
complex, which simultaneously forms a new biaryl bond and reduces Pd back to its 
original state. The Pd is then poised to undergo the cycle again.  
 Although most of these coupling methods are extremely robust, they still have 
short-comings. All of these methods have one main problem: the aryl groups must be 
prefunctionalized with halogens and metals. This is costly in terms of the time 
required to make the prefunctionalized aryl-metals and aryl-halides, and in terms of 
the waste generated from the additional reactions and purification steps.7 Therefore, 
“greener” methods to synthesize these biaryl bonds are being sought. 
 4 
 
 A method that would cut out costly prefunctionalization steps and couple 
simple hydrocarbons, would be ideal. Therefore, much research has lately been 
focused on cross-dehydrogenative coupling (CDC) as a means to synthesize biaryls.  
CDC is desirable due to the fact that two simple C-H bonds can be coupled, throwing 
out the need to prefunctionalize and giving a higher overall step economy. 
 Mechanistically, palladium-catalyzed CDC differs from traditional coupling 
techniques because it undergoes a Pd(II)/Pd(0) catalytic cycle instead of a Pd(0)/Pd(II) 
catalytic cycle. Because Pd(0) is not able to oxidatively insert into a C-H bond, a 
Pd(II) source is used to facilitate two separate C-H activations through means such as 
concerted metalation deprotonation or electrophilic aromatic metalation.8-9 (Scheme 3) 
Once the aryl groups are loaded onto the Pd, reductive elimination then occurs 
generating the product and leaving Pd in its reduced state. The final step is to oxidize 
Pd(0) back up to Pd(II) for the cycle to start again.  
 
       Scheme 3- Catalytic Mechanism for CDC 
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 When comparing traditional coupling techniques to CDC, it is clear that CDC 
is the greener method. For economical and environmental reasons, it appears that the 
future of biaryl coupling should be in CDC. Much research is now being devoted to 
developing new aryl-aryl CDC reactions and making them as green as possible by 
eliminating superfluous reagents from the reaction. The research described herein will 
provide an in depth look into cross-dehydrogenative coupling, by examining its 
advantages and shortcomings, and how it can be utilized in the formation of aryl-aryl 
bonds.      
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MANUSCRIPT 1 
 
Aryl-Aryl Bond Formation via CDC Reactions 
 
Abstract 
The formation of biaryl motifs via oxidative coupling of hydrocarbons is a 
challenging and highly sought after process in both academia and industry. 
Contemporary biaryl coupling techniques include prefunctionalization steps that lower 
the overall step economy of the reaction and increase expenses and waste. The cross 
coupling of C-H bonds is a green technique that requires no prefunctionalization and 
can significantly lower wasteful byproducts. This chapter highlights advances in the 
field of oxidative coupling of hydrocarbons through biaryl cross-dehydrogenative 
coupling (CDC). It includes insight into a variety of CDC methods including aerobic 
coupling and metal catalyzed CDC using metals such as: Pd, Rh, Ru, and Cu.   
General Introduction 
 
Currently there is a need for environmentally friendly ways to incorporate 
carbon-carbon bonds into organic molecules. Specifically, biaryl C-C bonds are of 
high priority, since aryl or heterocyclic groups are contained in 75% of marketed 
pharmaceuticals.1 The traditional methods for making biaryl C-C bonds include 
Suzuki, Negeshi, Stille, and Kumada coupling,2 all of which involve the coupling of 
an aryl-halide and an aryl-metal species. These methods might appear green since they 
use small quantities of metal catalysts and require no external oxidant. However, they 
suffer from wasteful and costly prefunctionalization steps and poor atom economy.3 
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The ideal scenario would be to oxidatively couple two aryl C-H bonds and 
produce a new biaryl C-C bond. This coupling method, herein known as cross-
dehydrogenative coupling (CDC), would require no prefunctionalization steps and 
generate fewer byproducts as waste (Scheme 1).  
 
 
 
Compared to traditional coupling techniques, CDC would provide a greener 
synthetic route by improving the overall step economy of the reaction, since 
functionalization is not a prerequisite in CDC. The number of additional steps required 
to install functional groups prior to coupling is often time consuming, expensive, and 
wasteful.   
In 1912, the first oxidative biaryl coupling was reported by Scholl, in which 
simple arenes were coupled using a stoichiometric amount of AlCl3.4-5 Since the 
introduction of the Scholl reaction, publications of biaryl CDC reactions have 
continued to grow, attracting much interest in both academic and industrial settings. 
However, these reactions come with many challenges that must be overcome before 
they can be implemented in industry. 
Scheme 1- Biaryl Synthesis via CDC and Traditional Suzuki Coupling Techniques 
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One of the main challenges with CDC methodology is finding ways to readily 
activate C-H bonds, since they are short, strong, and hard to activate via oxidative 
addition with organometallic complexes. Traditional coupling methods, such as the 
Suzuki reaction, are successful because prefunctionalization with a halogen or boronic 
acid creates species that are amenable to metalation via oxidative addition or 
transmetallation. Another challenge is using inexpensive and readily available 
oxidants. Coupling between two C-H bonds could ideally produce hydrogen gas as a 
byproduct; however, that is often thermodynamically unfavorable; thus, requiring an 
external oxidant to drive the reaction forward.6 Finally, controlling the selectively of 
C-H activation has proved difficult. Unwanted dimer byproducts often plague CDC 
reactions, and finding conditions that minimize homocoupling is difficult. 
Regioselectivity is the other selectivity problem due to the omnipresence of C-H 
bonds. Many times this is resolved by the use of a preinstalled directing group that can 
coordinate with a metal catalyst to facilitate insertion into a nearby C-H bond. 
Despite the difficulty of biaryl synthesis via CDC, much progress has been 
made on the subject over the past century, with most of the advances being realized in 
the past decade. This chapter will focus on some of the exciting highlights and recent 
advancements of these green reactions. 
Pd Catalyzed CDC Systems 
 
Although many different metal catalysts have been used in oxidative coupling 
reactions, the most common ones are late transition metals, including Pd, Rh, Ru, and 
Cu.2 Undoubtedly, Pd is used in the majority of examples, probably due to its high 
versatility and activity.7 The first biaryl dehydrogenative coupling reaction catalyzed 
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by Pd was reported by Van Heldon and Verberg, in which biphenyl was formed in 
high yields.8 This initiated a wave of studies using Pd catalysts in CDC reactions.  
Because Pd(0) has the potential to easily form a colloid and fall out of solution, a 
ligand or solvent system that can coordinate Pd(0) can be used to ameliorate this 
problem.9 However, the phosphine ligands that are commonly employed in traditional 
cross coupling chemistry are not stable in the oxidizing environments required for 
most CDC reactions, so simple palladium salts are often used, such as Pd(OAc)2 or 
PdCl2.7 Hartwig and co-workers observed that ligandless anionic palladium species 
more readily cleave C-H bonds compared to hindered phosphine ligated palladium 
catalysts.10 Thus providing evidence as to why most Pd catalyzed CDC reactions work 
efficiently without ligands. Pd catalyzed CDC reactions typically run in an acidic 
medium for up to several days11 at a temperature over 100 °C. An external oxidant is 
needed in these reactions. The greenest option is to use O2; though, other less green 
alternatives including peroxysulfates and metal salts of Cu(II) or Ag(I) are more 
common. 
Molecular Oxygen as an Oxidant and Ligand Controlled Regioselectivity. 
Several groups have successfully utilized molecular oxygen as the sole oxidant in 
aerobic Pd catalyzed biaryl CDC reactions. These reactions are probably the greenest 
CDC reactions that exist right now due to the fact that using O2 or air as the oxidant is 
inexpensive and makes water as a final biproduct. Most of these O2 oxidized reactions 
take place in an acidic environment and at temperatures ranging anywhere from 55-
120 oC.  
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In 1973, Yoshimoto and Itatani successfully carried out a biaryl Pd catalyzed 
dehydrogenative coupling reaction with pressurized O2 as the oxidant.12 They coupled 
biphenylethers intramolecularly, but also got an equal amount of intermolecular 
dimers as side products. The experimental conditions were harsh (50kg/cm2 of 1:1 
oxygen and nitrogen and heated to 150 °C) and were not regioselective. In 1999, 
Akermark and co-workers published a Pd catalyzed CDC reaction that 
intramolecularly coupled arylaminoquinones.13 This reaction worked in only 1 atm. of 
O2; however, when coupling biphenylethers or biphenylamines, the reaction required 
additional tin(II) acetate additives to prevent bulk Pd from falling out of solution.  
Later, the groups of Fagnou, Ohno, and Kandekar developed improved 
intramolecular aerobic CDC examples in which all experimental conditions included a 
Pd(OAc)2 catalyst, a base, pivalic or acetic acid, and oxygen (Scheme 2). These 
reactions were successful on biphenylethers14 and biphenylamines14-15 up to 99% yield 
and N-benzoylindoles14,16 and N-benzoylpyrroles17 up to 92% yield. 
 
 Scheme 2- Pd-catalyzed Aerobic Intramolecular CDC reactions 
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Several examples of aerobic intermolecular coupling via CDC of aryls were 
also published, using similar conditions.18-19 Perhaps the most interesting example to 
date was by Stahl and co-workers in 2011. They aerobically coupled indoles and 
arenes via intermolecular CDC using Pd catalysts and diazafluorene ligands.20 While 
optimizing the reaction, they found that both the anionic ligands in the Pd(II) salts and 
the neutral diazafluorene ligands could control regioselectivity (Scheme 3).  
 
 Scheme 3- Arylation of Indoles via CDC with Ligand Controlled Regioselectivity 
 
 
The combination of the pivalate anion with a diazafluorenone ligand was 
selective for C2 coupling, whereas the combination of the trifluoroacetate anion with a 
dimethyldiazafluorene ligand was selective for C3 coupling. In both catalyst systems 
the presence of electron donating groups deteriorated the regioselectivity; however the 
presence of electron withdrawing groups improved selectivity with the C2 selective 
catalyst system. 
Oxidant Controlled Regioselectivity. Another aspect that has been shown to 
readily influence site selectivity in CDC reactions is the choice of oxidant (Scheme 4).  
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   Scheme 4- Scope of Oxidant Controlled Regioselectivity 
  
In 2007, DeBoef and co-workers showed that regioselectivity could be 
manipulated in the arylation of benzofurans with different oxidants.21-22 They found 
upon examining the reaction in acidic conditions, that CDC reactions employing the 
heteropoly acid H4PMo11VO40 (HPMV) gave almost exclusive C2 site selectivity. The 
use of Cu(OAc)2 also gave moderate C2 selectivity, and the use of AgOAc gave no 
selectivity. That same year Fagnou and co-workers showed that, when arylating 
indoles, regioselectivity could be controlled by using different oxidants.23-24 They 
found that using Cu(OAc)2 gave C3 selectivity and using AgOAc gave C2 selectivity.  
Further studies have come from the DeBoef group on oxidant controlled 
regioselectivity, in which both benzofuran and indole arylations were examined in 
different solvent parameters.25-27 They summarized that solvent had little overall effect 
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on regioselectivity compared to oxidant choice,27 and both DeBoef and Fagnou 
reasoned that site selectivity is most likely due to the formation of polymetallic 
clusters during catalysis.23-24,25 
Catalytic Oxidants with O2 Terminal Oxidant. Using O2 as the only oxidant 
is, to date, the greenest condition for the synthesis of biaryls via CDC; however, 
several studies have shown that catalytic amounts of a metal oxidant can be used along 
with O2 as a terminal oxidant (Scheme 5).12,22,28-30  
 
 Scheme 5- Redox Cycle for a Pd catalyzed CDC with a catalytic metal oxidant  
                  and O2 terminal oxidant 
  
These “cocatalyst” oxidants are sometimes needed to help prevent bulk Pd 
from falling out of solution, they are often strong oxidants that can readily reoxidize 
Pd(0) back to Pd(II) before it falls out of solution.13 Transition metal salts, such as 
Sn(OAc)2,13, Ag2O,29 Cu(OTf)230 and Mn(OAc)3·H2O,31 have been used, but perhaps 
one of the most unique examples was by DeBoef and co-workers in which they used 
the heteropoly acid HPMV as a cocatalyst oxidant to afford high yields in the arylation 
of benzofurans via CDC reactions (Scheme 6). 22  
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Scheme 6- Aerobic arylation of benzofuran via Pd catalyzed CDC and catalytic HPMV oxidant 
 
 
Heteropoly acids have been shown to be quite efficient as catalytic oxidants 
due to their highly reversible oxidizability.31 The study utilized these efficient 
oxidants, and found that they contributed to high yields, and would tolerate substrates 
containing the presence of electron donating groups on the aryl moiety, which 
increased the reaction rate. Alternatively, the presence of electron withdrawing groups 
shut down the reaction.  Subsequent mechanistic studies have shown that the 
HPMV/O2-oxidized reactions proceed via a Pd(II)/Pd(IV) mechanism.27 
Organic Peroxide and F+ Oxidants. Another green oxidant option for Pd 
catalyzed biaryl CDC reactions is to use organic peroxides or F+ oxidants such as 
sodium persulfate (Na2S2O8) or N-fluorobenzenesulfonamide (NFSI) (Scheme 7).  
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             Scheme 7- Pd Catalyzed CDC reactions utilizing organic peroxide and F+ oxidants 
 
 
All of these are strong oxidants and are simultaneously inexpensive and 
environmentally friendly, since they do not contain transition metals.32 Given that 
these peroxides and F+ reagents are even stronger oxidants than most metal salts, it has 
been proposed that they are capable of causing the CDC to go through a Pd(II)/Pd(IV) 
catalytic cycle rather than the usual Pd(0)/Pd(II).34-36  A directing group is used in 
most of the Pd catalyzed biaryl CDC reactions with organic oxidants, most likely to 
help control site selectivity.   
The oxidant, sodium persulfate, has been used in several Pd catalyzed biaryl 
CDC reactions by such groups as Dong, Cheng, Lu, and Knochel, all of which also 
used a strong acid, such as TFA.32-34,37-39 Strong acids are proposed to aid metallation 
of the C-H bond by increasing the electrophillicity of the Pd catalyst.32 These biaryl 
CDC reactions oxidized by sodium or potassium persulfate couple simple arenes 
(several with directing groups), and can even be used to make phenanthridinone 
derivatives (e.g. 1, Scheme 7).33 The Dong group has also shown that using sodium 
persulfate is an effective oxidant in the CDC of arenes with O-pheynylcarbamates.32 
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Their coupling reaction achieved up to 98% yield and worked on a large library of 
substrates (e.g. 2, Scheme 7).  Finally, exciting new work has come out of the labs of 
Yu and Seayad that utilize F+ oxidants.35-36 These F+ oxidants were used along with Pd 
catalysts and ligand sources to couple simple arenes35 or arylate furans36 in yields up 
to 85% (e.g. 3, Scheme 7).  
Stoichiometric Metal Oxidants. The most widely used conditions for biaryl 
CDC reactions require stoichiometric amounts of metal oxidants. Although 
stoichiometric metal oxidants make them the least green of all the Pd catalyzed CDC 
reactions, they are still attractive due to the fact that the starting materials do not need 
prefunctionalization. The most frequently used metal oxidants are Ag(I) and Cu(II) 
salts. Both have been shown to work readily in the inter- and intramolecular coupling 
of simple arenes and heterocycles, and as seen in the section Molecular Oxygen as an 
Oxidant and Ligand Controlled Regioselectivity, DeBoef and Fagnou have even 
shown that metal oxidants influence regioselectivity.21-27  
Silver (I) salts have been used extensively as oxidants in many different types 
of biaryl CDC reactions, such as the arylation of indoles,23-24,40-42 azoles,43 
thiophenes,44 chromones,45-46 xanthines,47 uracils,48 and pyridine N-oxides.41-42,49 They 
are also used in inter- and intramolecular coupling of simple arenes.50-55 Recently, 
Zhang and co-workers oxidatively coupled thiophene derivatives and fluorinated 
arenes, using only 2.5 mol percent of Pd(OAc)2 as a catalyst and AgCO3 as an oxidant 
(Scheme 8).44  
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         Scheme 8- Pd Catalyzed CDC of Thiophenes and Fluorinated Arenes with a Ag(I) Oxidant 
 
 
Their reaction worked on a large library of thiophene substrates, and was even 
shown to arylate benzofurans and indoles in the same conditions. The reaction also 
tolerated a vast array of functionalities including, amides, esters, aldehydes, and 
olefins. These perfluoroarene-thiophene compounds are being used in various 
electronic materials including diodes and transistors,44 making Zhang’s reaction a 
superior way to produce these materials.  
Another interesting Pd catalyzed CDC reaction with a Ag oxidant was reported 
by the Sanford group in which they intermolecularly coupled arenes in high yields and 
high regioselectivity (Scheme 9).55  
 
       Scheme 9- Pd catalyzed CDC of benzoquinoline and arenes with a Ag(I) oxidant 
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Intermolecular coupling between two arenes is less common due to the fact 
that heterocycles are easier to regioselectively functionalize due to the intrinsic 
electronic differences of the C-H bonds.55 The Sanford group solved this problem by 
using benzoquinoline as one of their coupling partners. The substrate’s basic nitrogen  
served as a directing group that coordinated Pd and, thus, controlled site selectivity. 
They were able to achieve moderate to high yields, even in the presence of electron 
withdrawing and electron donating functionalities on the arenes.           
Copper(II) salts are commonly used oxidants. They are relatively inexpensive, 
and have been shown to work in a wide array of Pd catalyzed CDC reactions such as 
the arylation of heterocycles,22-25,27,56-57 and intermolecular coupling of arenes.58 
However in biaryl synthesis, they are chiefly utilized in intramolecular couplings22,59-64 
and the cross coupling of heterocycles.64-67  
In 2011, Greaney and co-workers used a Cu(OAc)2 oxidant with a Pd(OAc)2 
catalyst for an intramolecular CDC reaction that created medium-sized, biaryl-
containing rings (Scheme 10).62 
 
Scheme 10- Medium ring synthesis via intramolecular Pd catalyzed CDC with a Cu(II) oxidant 
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This reaction was unique in that it formed seven- and eight-membered rings, 
instead of the usual aromatic five member rings, as in the formation of 
carbozoles.15,30,51,60 Medium-size rings occur naturally in many biologically active 
compounds, and are generally more difficult to synthesize than small rings and large 
macrocycles, making methods for their synthesis highly desirable.62 Greaney’s group 
was able to achieve the synthesis of these rings and incorporate indole into their 
products, since indole is a common biologically active moiety. The reaction gave high 
yields, and worked with several other heterocycle coupling partners, like azoles. It also 
had an exceptional tolerance for amine and ether functionalities within the newly 
formed rings. 
Another interesting Pd mediated reaction with a Cu(II) oxidant comes from a 
study by the You group in 2011, in which they were able to cross couple heterocycles 
in high yields with good regioselectivity (Scheme 11).67  
 
 Scheme 11- Pd catalyzed cross coupling of heterocycles with a Cu(II) oxidant 
  
 
You used a [Pd(dppf)Cl2] catalyst and a Cu(OAc)2·H2O oxidant system. They 
also added a catalytic amount of X-Phos ligand, to prevent decomposition of indole 
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derivatives, and a CuCl additive, that further helped control regioselectivity. The 
reaction conditions were found to couple a wide array of heterocycles including, 
xanthines, pyridine N-oxides, azoles, indoles, and pyrroles in good to excellent yields. 
 
Rhodium and Ruthenium Catalyzed CDC Systems 
Catalysts based on rhodium and ruthenium are becoming increasingly popular 
for the synthesis of biaryls via CDC reactions. Palladium catalysts, although they 
exhibit good functional group tolerance and require mild reaction conditions, often 
need 10-20 mol % catalyst loading and a gross excess of one of the coupling substrates 
for a reaction to reach completion.68 Rhodium and ruthenium, on the other hand, have 
many of the same catalytic properties as Pd,68 but usually require less catalyst loading 
(1-5 mol %) and have potentially novel selectivity properties.69 Newfound interest in 
these metals as catalysts for biaryl CDC has been growing since a study on Ru 
catalyzed dehydrogenative coupling of 4-pyridines by Suzuki and co-workers in 
2007.70  
Rhodium catalyzed oxidative biaryl coupling is still in its infancy, given that it 
first started appearing in independent studies by Glorius, Miura, and You in 2012. All 
of these studies used either Rh(I) or Rh(III) catalysts and Cu(II) oxidants to carry out 
arylations of heterocycles,68 intramolecular couplings71 or dual heterocycle 
couplings.69,72  
One example by Glorius and co-workers showed that a Rh(III) catalyst in the 
presence of a AgSbF6 cocatalyst, could successfully couple two arenes with the use of 
a tertiary benzamide directing group (Scheme 12).68  
 23 
 
 
 Scheme 12- Rh catalyzed biaryl CDC with a tertiary benzamide directing group 
 
 
It was suggested that the AgSbF6 was involved in generating an electrophillic 
Rh(III) species as the active catalyst. This reaction was remarkable in that it took only 
5 mol% catalyst loading and achieved high yields and regioselectivity. Both electron 
withdrawing and electron donating groups were tried in different positions on the 
arenes resulting in moderate to high yields with close to a 3:1 meta/para 
regioselectivity in most cases. It is also interesting to note that the reaction did not 
couple to the ortho position of bromobenzene; making it possible to exclusively 
synthesize meta-substituted biaryls using 1,3-haloarenes.     
Ruthenium has been used in several oxidative homocoupling reactions;70,73-74 
however, its use in oxidative cross coupling is brand new. The You group recently 
published the initial findings of a novel Ru catalyzed biaryl CDC, wherein 2-
methylthiophene was successfully coupled to both benzoquinoline and quinoxaline 
motifs (Scheme 13).72  
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Scheme 13- Ru catalyzed CDC of methylthiophenes with benzoquinolines and quinoxalines 
 
 
This reaction, although not extensively studied yet, exhibited moderate yields with 
high regioselectivity.  
 
Copper Mediated CDC Systems   
Palladium is used in the majority of biaryl CDC reactions; however copper 
would be an ideal economical alternative since it is abundant and relatively 
inexpensive.75 It has seen historical use in oxidative naphthyl homo-couplings to 
synthesize chiral ligands like BINOL.76-78 Although, due to the radical nature of the 
reaction, the hetero-coupling of naphthyls has proved to be a difficult task since 
radical-radical recombination produces a majority of homo-coupled products.79 
Several groups have found solutions to this,79-83 including Collins and co-workers, 
who used NHC (N-heterocyclic carbene) ligands in a bis-NHC-Cu(II) complex to 
catalyze the cross coupling of naphthyl derivatives via CDC (Scheme 14).79  
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       Scheme 14- CDC of naphthyl derivatives by a N-heterocyclic carbene-Cu(II) complex 
 
 
The presence of the NHCs greatly effects the electronic properties of the Cu(II) 
making it possible to cross couple naphthyls. The CDC was believed to proceed via a 
radical-addition mechanism. 
All other Cu mediated CDC reactions fall under two groups: Daugulis 
iodination conditions,84-85 and Miura’s CDC arylation of heterocycles.75 Daugulis’s 
conditions include the presence of a Cu(I) salt and I2 (Scheme 15).85  
 
 Scheme 15- Daugulis conditions for iodination and direct arylation using CuI/I2 
 
 
It is known to proceed through a one-pot iodination and then Cu mediated 
direct arylation. The fact that the reaction is prefunctionalizing one of the C-H bonds 
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perhaps makes it not a true CDC; however, the reaction requires no initial 
functionalization steps beforehand giving it the outward appearance of a CDC. 
Daugulis and co-workers have used their CuI/I2 conditions on the coupling of a vast 
array of heterocycles as well as both electron rich and electron poor substrates, making 
this a highly versatile reaction.   
The final category of Cu mediated biaryl CDC is the work by Miura and co-
workers in 2011. Miura was able to cross couple arenes with a variety of azoles using 
excess Cu(OAc)2 (Scheme 16).75  
 
 Scheme 16- Cu catalyzed CDC of pyridyl arenes and azoles 
 
 
The reaction gave moderate yields, and the use of a directing group on the 
arenes provided high regioselectivity. Even though this reaction used excess 
Cu(OAc)2, it is still desirable because copper is more economical than other catalytic 
metals like Pd. Daugulis86 and Mori87 have successfully shown that catalytic Cu can 
be used in aryl oxidative dimerizations. Therefore, the goal of using Cu in catalytic 
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amounts for biaryl CDC, aside from radical naphthyl or iodination coupling, seems 
promising.  
 
Other CDC Systems  
To date there are only a few other examples of CDC systems used for biaryl 
coupling. The majority of them fall under single electron transfer (SET) oxidants like 
hypervalent iodine reagents. Kita and co-workers have monopolized the field of using 
hypervalent iodine in biaryl CDC reactions.88-92  
 Hypervalent iodine oxidants are known to be safe,88 mild oxidants89 that can 
readily form aromatic cation radicals with electron rich arenes through SET.90 They 
usually require low temperatures and short reaction times. Unwanted dimerization can 
often plague these aryl CDC reactions, so Kita typically uses one coupling partner like 
naphthalene, which is electron rich and prone to forming an aromatic cation radical 
with a hypervalent iodine oxidant, and a second coupling partner that is more 
nucleophillic so as to cause a nucleophillic attack on the radical and subsequent cross 
coupling.90 Kita and co-workers have also shown that using hypervalent iodine 
reagents to couple thiophenes can form intermediate thienyl iodonium(III) salts 
(Scheme 17).89 The formation of these intermediate salts effectively eliminates 
dimerization and gives excellent regioselectivity. The reaction tolerated a large library 
of functionized arenes and heterocycles and gave moderate to high yields.   
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Scheme 17- Hypervalent iodine mediated CDC of thiophenes with arenes and heterocycles 
 
 
  A few remaining CDC systems include V(V) catalytic systems,93 and Tl(III) 
catalytic systems;94-95 both of which have been used in intramolecular aryl coupling 
via free radicals, although in low yields and harsh reaction conditions. Autoxidizing 
CDC conditions developed by Bergman are also of interest, in which one of the 
coupling partners, quinoline, serves as the sole oxidant as it is coupled to indole or 
pyrrole moieties.96 Finally, the use of iron in biaryl CDCs is also being developed.97-99  
Katsuki and co-workers published a study in 2011 on an aerobic Fe catalyzed cross 
coupling of naphthol derivatives to make unique BINOL ligands (Scheme 18).97  
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      Scheme 18- Aerobic Fe catalyzed CDC of naphthols 
 
 
This reaction was quite green since it used an iron catalyst, which is non-toxic 
and inexpensive, and only a 4 mol % catalyst loading. Also, the oxidant was molecular 
oxygen from the air, giving off water as a biproduct. The reaction was suggested to go 
through a radical-addition, and produced moderate yields and high enantioselectivity 
on a wide range of substrates. This makes it a desirable new method for synthesizing 
enantiomeric BINOL ligands. 
Future efforts in the CDC of arenes will perhaps include enzyme mediated 
reactions, since enzymes have low toxicity, high catalytic turnovers, and are able to 
run in very mild conditions. In 2006,100 d’Ischia and co-workers used peroxidase 
enzymes to catalyze the oxidative dimerization of indole derivatives. This technology, 
albeit low yielding, appears to be an excellent lead to optimize for cross-
dehydrogenative coupling. 
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MANUSCRIPT 2 
 
Intramolecular Arylation of Benzimidazoles via Pd(II)/Cu(I) catalyzed Cross- 
Dehydrogenative Coupling 
 
Abstract 
Electron poor benzimidazole substrates were arylated via an intramolecular 
cross-dehydrogenative coupling (CDC) reaction. These CDC reactions were catalyzed 
by a Pd(II)/Cu(I) catalyst system, capable of producing moderate yields on a large 
library of substrates. The substrate scope consisted of tethered arene-benzimidazoles 
that upon coupling, produced a fused polycyclic motif. 
 
Introduction 
 
The biaryl motif is a prominent structure in many biologically active 
compounds, and green methods to synthesize these biaryl bonds are highly desired.1 
Conventional aryl coupling methods (i.e. Suzuki2 or Stille3 coupling) contain 
prefunctionalization steps to form activated C-metal or C-halogen bonds, which can 
readily undergo catalytic coupling. However, this prefunctionalization decreases the 
overall step economy of the synthesis and produces large amounts of waste. A far 
more advantageous coupling method would be cross-dehydrogenative coupling 
(CDC). It can be used to inter- and intramolecularly couple two aryl hydrocarbon 
bonds, requiring no prefunctionalization of substrates and affording high yields with 
minimal byproducts and waste (Scheme 1). 
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Much attention has been given to incorporating heterocycles into biaryl CDC 
reactions, since heterocyclic components are often found in nature and a play a 
prominent role in pharmaceutical candidates.1 The benzimidazole moiety alone has 
been shown to have many important uses including an antiviral for HIV-1,4 
antibacterials,5-6 and possible anticancer agents.7 However, imidazoles are rarely 
found as a coupling substrates in CDC reactions. Mori and coworkers have shown an 
efficient homocoupling reaction for imidazoles,8 and the You group has found success 
coupling imidazoles to electron rich substrates like thiofurans.9-10 However, oxidative 
coupling between imidazoles and benzenes has proved to be a challenging task. 
Dominguez and Dubois have arylated imidazoles using aryl iodides,11-12 but, to our 
knowledge, the only example of coupling imidazoles with simple arenes via CDC is 
the coupling of N-styryl-imidazoles by Bao and coworkers.13      
 With this in mind, we decided to try palladium catalyzed CDC reactions 
between benzimidazoles and arenes. To help overcome coupling difficulties, the arene 
was tethered to the benzimidazole prior to coupling by installing an N-benzyl 
       Scheme 1- The Conventional Suzuki-Miyaura Cross Coupling Method vs. CDC 
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substituent. The tether would help in the metallation of both coupling partners by 
keeping them in close proximity to each other, and at the same time reducing 
unwanted dimerization. CDC should cause this tethered substrate to cyclize into a 
fused polycyclic system.  
           
Results and Discussion 
 
 The optimization studies for this reaction were performed on N-benzyl 
benzimidazole, substrate 1, which was synthesized through a substitution reaction 
using deprotonated benzimidazole and benzyl chloride. Substrate 1 was then purified 
by column chromatography and afforded a 70% yield. Initially, we thought that a 
Cu(I) halide source  would be a beneficial catalyst since it has been shown that CuI 
can arylate the C2 position on azoles via intramolecular coupling with aryl iodides.11 
Since 1 did not contain a halogen, it was also theorized that a catalyst such as 
Pd(OAc)2 would be needed to activate the aryl C-H bond. However both 
Pd(OAc)2/CuI and Pd(OAc)2/CuCl catalyst systems proved to be ineffective, since 
they both gave low conversion of starting materials and a mixture of byproducts. Next, 
a rhodium based catalyst, [RhCl(coe)2]2, was tried, but it suffered from low yields and 
dimerization. Simply using Pd(OAc)2 as the catalyst with a Cu(OAc)2·H2O oxidant 
provided a superior system, therefore further optimization reactions were run with this 
catalyst system (Table 1). 
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At the outset, undesired byproducts including the dimer 4 and the acetoxylated 
compound 3 plagued the reaction. It was found that lowering the amount of 
Cu(OAc)2·H2O oxidant helped reduce the amount of acetoxylated products since the 
amount of acetate anion was reduced. Also simply lowering the temperature and time 
of the reaction helped lower byproduct formation. Interestingly, the addition of 
CsOPiv (Table 1, entry 5) eliminated compound 3, most likely due to the steric nature 
of the pivalate anion. It has been suggested by Fagnou that the addition of pivalate 
helps facilitate C-H bond cleavage by forming Pd(OPiv)2 prior to palladation.14-16 
Fagnou and coworkers also showed that reactions performed in pivalic acid instead of 
acetic acid greatly reduced unwanted oxidative byproducts including dimers.14   
Upon doubling the amount of Pd(OAc)2, compound 2 was recovered in a 
nearly twofold yield (Table 1, entry 6), suggesting that catalyst turnover was a 
problem in the reaction. After many trials, the optimal time and temperature for the 
coupling reaction was found to be 3 hours at 150 ºC under microwave heating (Table 
Table 1- Optimization of the Reaction Conditions 
 42 
 
1, entry 8). The longer reaction times led to a decrease in product, perhaps due to 
decomposition (Table 1, entry 9). Finally, we were excited to discover that the 
addition of 0.5 equivalents of CuOAc, improved the yield, giving the best isolated 
yield of 58% (Table 1, entry 10).  
Another interesting observation during the optimization of this reaction was 
the copper coloration present in the organic layer while extracting the product. Cu(II) 
has been known to coordinate to pyrazole ligands in isolatable complexes;17 thus we 
speculated that copper was forming a complex with our benzimidazole products, and 
therefore lowering the isolated yield. A stronger ligand was perhaps needed to remove 
the copper and free the final product. Immediately following the coupling reaction, we 
added Na2S·9H2O to the reaction and stirred at room temperature for an hour. This 
removed all copper coloration from the organic extract, and simultaneously increased 
the yields of the coupled product.  
Next, an array of substrates was screened with the optimized conditions to 
determine the scope of the reaction (Table 2). Comparing compounds 2, 5, 16, and 17 
gave evidence that the presence of an electron donating group on the benzimidazole 
moiety increased the coupling yield; however, electron withdrawing functionalities on 
the benzimidazole, compound 9, seemed to hinder coupling. When comparing electron 
rich and electron poor arene coupling partners, there didn’t appear to be a significant 
trend in reactivity. The starting materials for products 8, 9, and 13 were synthesized in 
inseparable mixtures, thus the cyclization reactions produced mixtures of isomers.  
The cyclization was successful in forming a new six-membered ring, compound 21, 
but failed to couple compounds 19 and 20, which would have produced new seven 
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membered rings. This indicated that the length of the tether highly influenced the 
success of the reaction.  
 
Table 2- Scope of the Cyclization of N-benzylbenzimidazolesa 
 aReaction conditions: 0.384 mmol substrate, 20 mol% Pd(OAc)2, Cu(OAc)2•H2O (0.768 
mmol), CuOAc (0.192 mmol), CsOPiv (0.960 mmol) in 5 mL of 1,4-dioxane at 150 ˚C 
for 3 hr under microwave heating. Isolated yields throughout.   
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Intramolecular coupling reactions between benzimidazole and other 
heterocycles, such as furan, imidazole, and the caffeine derivative, benzyl 
theophylline, were also tried under our optimized conditions; however, the attempts 
were unsuccessful. (e.g. 12, 14, 22, Table 2). 
Kinetic isotope effects of the reaction were evaluated by carrying out 
competition studies. The first competition study utilized equimolar amounts of N-
benzylbenzimidazole and deuterated N-benzyl-d7 benzimidazole, and subjected both 
substrates to the optimized coupling conditions. Relative amounts of the products were 
obtained from GC-MS analysis and a KIE of 1.03 was obtained (Scheme 2). This 
indicated that the metalation of the arene coupling partner was not rate limiting, but 
more of a facile step in the reaction.18 A second competition study was carried out 
with equimolar amounts of N-benzylbenzimidazole and N-benzyl-3-
deuterobenzimidazole, but the KIE results of this test proved to be inconclusive due to 
H/D scrambling. 
 
 
Scheme 2- KIE Study on Aryl-Benzimidazole Cyclization 
 
With the KIE studies in hand, we sought to propose a plausible mechanism for 
this unique intramolecular CDC reaction. Based on all data, it seemed that the 
coupling was taking place through a PdII/CuI catalyzed system. Our reasoning behind 
the dual metal catalysis was supported by several factors. It was known from previous 
studies that Cu(I) was capable of enhancing azole coupling,8-11 so we speculated that  
Cu(I) was needed to activate the C2 position of the benzimidazole. Because the 
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addition of Cu(I) only raised the percent yield slightly (Table 1, entry 10), we needed 
to be sure that the addition  of Cu(I) was in fact essential in the formation of the 
product. Since the Cu(OAc)2 oxidant could diporpotionate into Cu(I), we theorized 
that there was perhaps some Cu(I) present to catalyze the reaction. This would explain 
why we did not see a significant raise in yield upon the addition of a Cu(I) source.  
To test whether Cu(I) was utilized in the mechanism, we had to eliminate the 
use of Cu(OAc)2 as an oxidant. (Scheme 3) A control was carried out using AgOAc as 
an oxidant and Pd(OAc)2 as the only catalyst. The GC-MS results showed that there 
was low conversion of the starting material into a small amount of the acetoxylated 
product 2 and dimer 4. None of the desired arylation product 2 was formed, suggesting 
that Cu is needed in the reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3- Control Reactions Using AgOAc as an Oxidant 
 
We next ran a second control using only a Cu(I) catalyst and AgOAc as the 
oxidant. The GC-MS results showed there was a low conversion of the starting 
material into the dimer 4. (Scheme 3) Consequently, we concluded that Cu(I) could 
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activate the benzimidazole moiety and form the benzimidazole dimer. This control 
also supported that Pd played a pivatol role in the activation of the arene for coupling. 
Our proposed mechanism (Scheme 4) utilizes two independent metalation 
steps. First, Cu(I) inserts in the 2 position of benzimidazole, forming acetic acid and a 
Cu(I)-benzimidazole complex. Next, the arene is palladated, again producing acetic 
acid as a byproduct. At this point, a transmetalation could occur in which CuOAc is 
released and a biaryl Pd(II) complex is formed. The final step of the reaction would 
include a simple reductive elimination to form the coupled aryl-benzimidazole product 
and Pd(0).  Subsequent oxidation of the Pd by the Cu(OAc)2 oxidant would regenerate 
both the Pd(II) and Cu(I) catalysts. To our knowledge, two independent C-H 
activations by different metals followed by a single transmetallation, is a novel 
mechanism, and would warrant future investigations.  
 
 
Scheme 4-Proposed Mechanism for the Pd(II)/Cu(I) Catalyzed Cyclization of N-
benzylbenzimidazoles 
 
Based on the KIE studies, it was concluded that the palladation of the arene is 
not rate limiting and does not go through a concerted metalation deprotonation (CMD) 
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mechanism. Instead it more likely proceeds through some kind of electrophilic 
aromatic metalation. For a CMD mechanism a much higher KIE value of 3-4 would 
have been expected, since the rate limiting step consists of simultaneous C-H bond 
cleavage and palladation. Electrophilic metalation on the other hand, would have a 
lower KIE value, since palladation occurs before deprotonation. Electrophilic 
palladation of the arene causes a loss of aromaticity, which provides for easy 
subsequent deprotonation of arene in order to restore aromaticity.     
 
 
Conclusions 
 
In conclusion, we have developed an intramolecular coupling reaction between 
the 2-position of benzimidazole and a tethered arene to form fused polycyclic 
heterocycles. The use of cross-dehydrogenative coupling in this reaction makes it 
highly atom economical and cost efficient, since no prefunctionalization is required. 
Mechanistic investigations led us to propose that the reaction proceeds via a dual 
PdII/CuI catalyst system with a Cu(OAc)2 oxidant. A large library of electron poor and 
electron rich arene-benzimidazoles were coupled in moderate yields, suggesting that 
this reaction could be a valuable tool in the synthesis of biologically useful 
heterocyclic compounds. 
    
Methods 
 
Representative Procedure for CDC Coupling. A magnetically stirred solution of N-
benzylbenzimidazole (82 mg, 0.395 mmol), palladium acetate (18 mg, 0.076 mmol), 
copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg, 
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0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was 
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide 
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room 
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to 
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude 
product was then purified via column chromatography to give pure 2 (82 mg, 53% 
yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy.  
Representative Procedure for Synthesizing N-Tethered Starting Materials.  Under 
an inert nitrogen atmosphere, benzimidazole (4.0 g, 33.8 mmol) was added to a 
solution of potassium tert-butoxide (5.7 g, 50.8 mmol) in 40 mL of DMF at 0 ˚C and 
magnetically stirred for 15 minutes. To the mixture was added a solution of benzyl 
chloride (4.7 g, 37.3 mmol) in an additional 15 mL of DMF. The mixture was then left 
to warm to room temperature and stirred for 2 hours. After the reaction was complete, 
it was quenched with 90 mL of water and extracted three times with 90 mL portions of 
ethyl acetate. The organic extracts were washed with three 90 mL portions of water 
followed by three 90 mL portions of brine. The organic extracts were dried with 
magnesium sulfate and condensed at reduced pressure. The crude product was then 
purified via column chromatography to give pure N-benzylbenzimidazole (4.10 g, 
58% yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy. 
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Experimental Section 
 
 The novel compounds synthesized are reported below. 
 
Reagents 
 All reagents, including benzimidazoles, benzyl chlorides, sodium sulfide 
nonahydrate, potassium tert-butoxide, ethyl acetate, hexanes, 1-4-dioxane, copper(II) 
acetate monohydrate, copper(I) acetate, and cesium pivalate were purchased from 
Fisher Scientific and Sigma Aldrich and used without purification. Column 
chromatography was performed on Silicycle silica gel (60 Å, 40-63 µm). Palladium 
(II) acetate was purchased from Precious Metals Online 
(http://www.precmet.com/au/). It was then dried at 100 ˚C for approximately 6 hours 
under vacuum. All reagents were stored in an inert nitrogen atmosphere.  
 
 
Instrumentation 
 
 Reactions were carried out with a CEM Discover Microwave. A Bruker 
Avance 300 MHz spectrometer and a JEOL GSX 400 MHz spectrometer were used 
for NMR analysis. GC/MS analysis was carried out with an Agilent Technologies 
6890 GC fixed with a 5973 Mass Selective Detector. 
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Synthesis of 11-H-Isoindolo[2,1-a]benzimidazole (2) 
 
 
A magnetically stirred solution of N-benzylbenzimidazole (80 mg, 0.384 mmol), 
palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115 mg, 
0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg, 0.768 
mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the 
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the 
reaction mixture and stirred at room temperature for 1 hour. The mixture was then 
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was 
condensed at reduced pressure. The crude product was then purified via column 
chromatography to give pure 2 (45 mg, 58% yield). The product was analyzed by GC-
MS, and 1H NMR and 13C NMR spectroscopy. 
 
Rf-Value: Hexanes/Ethyl acetate (70:30 v/v) = 0.4  
1H NMR (300 MHz, CDCl3) δ= 8.02 (dd, J= 6.5 Hz, 1.39 Hz, 1H), 7.83-7.81 (m, 
1H), 7.53-7.44 (m, 3H), 7.39-7.36 (m, 1H), 7.26-7.23 (m, 2H), 4.95 (s, 2H) 
 
13C NMR (75 MHz, CDCl3) δ= 158.46, 148.34, 143.48, 132.63, 129.47, 129.32, 
128.70, 123.83, 122.64, 122.14, 121.98, 120.48, 109.32, 47.17 
 
LRMS EI (m/z): [M+] calc’d for C14H10N2 206.1, observed 206.2  
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 Spectrum 1- 1H NMR of Compound 2 
 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spectrum 2- 13C NMR of Compound 2 
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Synthesis of 3 
 
 
 
A magnetically stirred solution of N-benzylbenzimidazole (125 mg, 0.6 mmol), 
palladium acetate (14 mg, 0.06 mmol), copper(II) acetate (479 mg, 2.4 mmol), and 4.5 
mL dioxane was microwave heated 160 ˚C for 1 hours. The mixture was then filtered, 
using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was condensed at 
reduced pressure. The crude product was then purified via column chromatography to 
give pure 3 (33 mg, 21% yield). The product was analyzed by GC-MS, and 1H NMR 
and 13C NMR spectroscopy. 
 
Rf-Value: Hexanes/Ethyl acetate (70:30 v/v) = 0.30 
1H NMR (300 MHz, CDCl3) δ= 7.97 (d, J= 7.4 Hz , 1H), 7.82-7.79 (m, 1H), 7.60-
7.57 (m, 2H), 7.55 (s, 1H), 7.52-7.47 (m, 2H), 7.30-7.27 (m, 2H), 2.24 (s, 3H) 
 
13C NMR (75 MHz, CDCl3) δ=170.98, 157.28, 148.60, 143.47, 131.89, 130.92, 
130.41, 129.44, 126.73, 125.03, 123.98, 122.94, 122.16, 120.76, 110.78, 20.93 
 
LRMS EI (m/z): [M+] calc’d for C16H12N2O2 264.1, observed 264.1 
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Spectrum 3- 1H NMR of Compound 3 
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Spectrum 4- 13C NMR of Compound 3  
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Synthesis of 7 
 
 
 
A magnetically stirred solution of N-(3-chlorobenzyl)-benzimidazole (0.093 mg, 0.384 
mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115 
mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg, 
0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the 
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the 
reaction mixture and stirred at room temperature for 1 hour. The mixture was then 
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was 
condensed at reduced pressure. The crude product was then purified via column 
chromatography to give pure 7 (13 mg, 15% yield). The product was analyzed by GC-
MS, and 1H NMR and 13C NMR spectroscopy. 
 
1H NMR (300 MHz, CDCl3) δ = 7.97 (d, J= 8.2 Hz, 1H) , 7.83 (dd, J= 6.0 Hz, 3.2 Hz, 
1H) , 7.56 (sd, J= 1.8 Hz, 1H) , 7.51 (dd, J= 8.2 Hz, 1.8 Hz, 1H) , 7.44 (dd, J= 6.0, 3.2 
Hz, 1H) , 7.30 (d, J=3.2 Hz, 1H) 7.29 (d, J=3.2 Hz, 1H), 5.04 (s, 2H) 
 
13C NMR (75 MHz, CDCl3) δ= 145.92, 139.03, 136.52, 130.22, 128.93, 125.31, 
123.91, 123.87, 123.75, 123.37, 123.03, 121.61, 110.30, 47.95 
 
LRMS EI (m/z): [M+] calc’d for C14H9ClN2 240.0, observed 240.0 
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Spectrum 5- 1H NMR of Compound 7 
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Spectrum 6- 13C NMR of Compound 7 
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Synthesis of 9 
 
 
 
A magnetically stirred solution of a mixture of N-benzyl- (5-nitro and 6-
nitro)benzimidazole (97 mg, 0.384 mmol), palladium acetate (18 mg, 0.076 mmol), 
copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg, 
0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was 
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide 
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room 
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to 
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude 
product was then purified via column chromatography to give pure 9 (26 mg, 29% 
yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy. 
 
1H NMR (300 MHz, CDCl3) δ= 8.69 (d, J= 1.7 Hz, 1H, isomer A), 8.40 (d, J= 1.7 Hz, 
1H, isomer B), 8.24-8.20 (m, 1H, isomer A and B) 8.09 (s, J= 3.84 Hz, 1H, isomer A 
and B) 7.85 (d, J= 9.0 Hz, 1H, isomer B), 7.64-7.56 (m, 3H, isomer A and B), 7.49 (d, 
J= 8.6 Hz, 1H, isomer A), 5.17 (s, 2H, isomer B), 5.13 (s, 2H, isomer A) 
 
13C NMR (75 MHz, CDCl3) (isomer A) δ= 143.50, 138.73, 133.12, 130.83, 129.24, 
124.16, 122.83, 120.21, 119.39, 118.77, 116.95, 109.04, 106.16, 47.63 
 
LRMS EI (m/z): [M+] calc’d for C14H9N3O2 251.1, observed 251.1 
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Spectrum 7- 1H NMR of Compound 9 
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Spectrum 8- 13C NMR of Compound 9 
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Synthesis of 11 
 
  
 
A magnetically stirred solution of N-(3-(trifluoromethyl)benzyl)-5,6-
dimethylbenzimidazole (117 mg, 0.384 mmol), palladium acetate (18 mg, 0.076 
mmol), copper(II) acetate monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 
mg, 0.192 mmol), cesium pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was 
microwave heated 150 ˚C for 3 hours. After the reaction was complete, sodium sulfide 
nonahydrate (0.6 g, 2.5 mmol) was added to the reaction mixture and stirred at room 
temperature for 1 hour. The mixture was then filtered, using 3 mL ethyl acetate to 
rinse the reaction vial, and the filtrate was condensed at reduced pressure. The crude 
product was then purified via column chromatography to give pure 11 (57 mg, 50% 
yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy. 
 
 
1H NMR (300 MHz, CDCl3) δ =  8.08 (d, J= 8.0 Hz, 1H) , 7.79 (s, 1H), 7.75 (d, J= 
8.0 Hz, 1H), 7.57 (s, 1H), 7.23 (s, 1H), 5.02 (s, 2H), 2.39 (s, 3H), 2.38 (s, 3H) 
 
13C NMR (75 MHz, CDCl3), 19F not decoupled δ= 143.67, 132.95, 132.86, 126.14, 
126.09, 125.72, 121.96, 121.00, 120.93, 120.88, 120.82, 120.79, 109.91, 47.22, 29.71, 
20.57, 20.40 
 
LRMS EI (m/z): [M+] calc’d for C17H13F3N2 302.1, observed 302.1 
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Spectrum 9- 1H NMR of Compound 11 
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Spectrum 10- 13C NMR of Compound 11 
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Synthesis of 15 
 
 
 
A magnetically stirred solution of N-(2-methoxybenzyl)-benzimidazole (80 mg, 0.33 
mmol), palladium acetate (15 mg, 0.067 mmol), copper(II) acetate monohydrate (101 
mg, 0.504 mmol), copper(I) acetate (21 mg, 0.17 mmol), cesium pivalate (157 mg, 
0.672 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the 
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the 
reaction mixture and stirred at room temperature for 1 hour. The mixture was then 
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was 
condensed at reduced pressure. The crude product was then purified via column 
chromatography to give pure 15 (34 mg, 43% yield). The product was analyzed by 
GC-MS, and 1H NMR and 13C NMR spectroscopy. 
 
Rf-Value: Hexane/Ethyl acetate (50:50 v/v) = 0.30 
1H NMR (300 MHz, CDCl3) δ= 7.83-7.80 (m, 1H), 7.63 (d, J= 7.6 Hz, 1H), 7.47-7.40 
(m, 2H), 7.27-7.24 (m, 2H), 6.92 (d, J=8.2 Hz, 1H), 4.90 (s, 2H), 3.90 (s, 3H) 
 
13C NMR (75 MHz, CDCl3) δ= 158.64, 155.05, 148.33, 132.70, 130.98, 130.68, 
130.46, 122.62, 122.04, 120.51, 114.35, 111.29, 109.33, 55.43, 45.39 
 
LRMS EI (m/z): [M+] calc’d for C15H12N2O 236.1, observed 236.1 
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Spectrum 11- 1H NMR of Compound 15 
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Spectrum 12- 13C NMR of Compound 15 
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Synthesis of 16 
 
A magnetically stirred solution of N-(4-methoxybenzyl)-(5,6-dimethyl)benzimidazole 
(102 mg, 0.384 mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate 
monohydrate (115 mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium 
pivalate (180 mg, 0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 
hours. After the reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) 
was added to the reaction mixture and stirred at room temperature for 1 hour. The 
mixture was then filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the 
filtrate was condensed at reduced pressure. The crude product was then purified via 
column chromatography to give pure 16 (64 mg, 63% yield). The product was 
analyzed by GC-MS, and 1H NMR and 13C NMR spectroscopy. 
 
1H NMR (300 MHz, CDCl3) δ = 7.49 (s, 1H), 7.44 (sd, J=2.3 Hz, 1H), 7.28 (d, J= 8.3 
Hz, 1H), 6.98 (s, 1H), 6.89 (dd, J=8.3 Hz, 2.3 Hz, 1H), 4.61 (s, 2H), 3.83 (s, 3H), 2.32 
(s, 3H), 2.26 (s, 3H) 
 
13C NMR (75 MHz, CDCl3) δ= 20.03, 20.40, 46.50, 55.53, 105.41, 109.54, 116.26, 
120.27, 124.34, 130.62, 130.74, 131.08, 131.70, 135.34, 146.61, 157.50, 160.04 
 
LRMS EI (m/z): [M+] calc’d for C17H16N2O 264.1, observed 264.1  
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Spectrum 13- 1H NMR of Compound 16 
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Spectrum 14- 13C NMR of Compound 16 
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Synthesis of 17 
 
 
 
A magnetically stirred solution of N-(4-methoxybenzyl)-benzimidazole (91 mg, 0.384 
mmol), palladium acetate (18 mg, 0.076 mmol), copper(II) acetate monohydrate (115 
mg, 0.576 mmol), copper(I) acetate (24 mg, 0.192 mmol), cesium pivalate (180 mg, 
0.768 mmol), and 5 mL dioxane was microwave heated 150 ˚C for 3 hours. After the 
reaction was complete, sodium sulfide nonahydrate (0.6 g, 2.5 mmol) was added to the 
reaction mixture and stirred at room temperature for 1 hour. The mixture was then 
filtered, using 3 mL ethyl acetate to rinse the reaction vial, and the filtrate was 
condensed at reduced pressure. The crude product was then purified via column 
chromatography to give pure 17 (49 mg, 54% yield). The product was analyzed by 
GC-MS, and 1H NMR and 13C NMR spectroscopy. 
 
1H NMR (400 MHz, CDCl3) δ= 7.80 (d, J= 7.0 Hz, 1H), 7.52 (s, 1H), 7.38-7.34 (m, 
2H), 7.25-7.22 (m, 2H), 6.98 (d, J= 8.4 Hz, 1H), 4.85 (s, 2H), 3.86 (s, 3H) 
 
13C NMR (101 MHz, CDCl3) δ= 160.23, 148.19, 138.10, 135.37, 132.72, 130.46, 
124.52, 122.62, 122.08, 120.43, 116.89, 109.31, 105.76, 55.61, 46.78 
 
LRMS EI (m/z): [M+] calc’d for C15H12N2O 236.1, observed 236.1 
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 Spectrum 15- 1H NMR of Compound 17 
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Spectrum 16- 13C NMR of Compound 17 
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Synthesis of N-benzylbenzimidazole 
 
Under an inert nitrogen atmosphere, benzimidazole (4.0 g, 33.8 mmol) was added to a 
solution of potassium tert-butoxide (5.7 g, 50.8 mmol) in 40 mL of DMF at 0 ˚C and 
magnetically stirred for 15 minutes. To the mixture was added a solution of benzyl 
chloride (4.7 g, 37.3 mmol) in an additional 15 mL of DMF. The mixture was then left 
to warm to room temperature and stirred for 2 hours. After the reaction was complete, 
it was quenched with 90 mL of water and extracted three times with 90 mL portions of 
ethyl acetate. The organic extracts were washed with three 90 mL portions of water 
followed by three 90 mL portions of brine. The organic extracts were dried with 
magnesium sulfate and condensed at reduced pressure. The crude product was then 
purified via column chromatography to give pure N-benzylbenzimidazole (4.10 g, 
58% yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy.  
 
Rf-Value: Hexanes/Ethyl acetate (30:70 v/v) = 0.40  
1H NMR (300 MHz, CDCl3) δ= 7.94 (s, 1H), 7.83 (dd, J= 8.1 Hz, 1.9 Hz, 1H), 7.33-
7.25 (m, 6H) 7.18-7.15 (m, 2H), 5.33 (s, 2H) 
 
13C NMR (75 MHz, CDCl3) δ= 143.96, 143.21, 135.45, 133.88, 129.00, 128.23, 
127.04, 123.04, 122.23, 120.41, 110.01, 48.77 
 
LRMS EI (m/z): [M+] calc’d for C14H12N2 208.1, observed 208.1  
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Spectrum 17- 1H NMR of N-benzylbenzimidazole 
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Spectrum 18- 13C NMR of N-benzylbenzimidazole 
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Synthesis of 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzo[d]imidazole  
 
 
Under an inert nitrogen atmosphere, tosyl chloride (2.33 g, 12.1 mmol) was added to a 
solution of furfuryl alcohol (1.08 g, 11.0 mmol) and triethylamine (2.0mL, 14 mmol) 
in 10 mL of methylene chloride at 0 ˚C. The reaction was magnetically stirred and 
allowed to warm to room temperature. It was monitored by TLC until the reaction was 
complete. A second reaction mixture of 5,6-dimethylbenzimidazole (3.38 g, 23.1 
mmol) and potassium tert-butoxide (3.87 g, 34.4 mmol) in 30 mL of methylene 
chloride was magnetically stirred for 30 minutes at room temperature. It was then 
cooled to 0 ˚C, and the first reaction mixture was added directly. The whole mixture 
was then left to warm to room temperature and stirred for 4-6 hours. After the reaction 
was complete, it was quenched with 50 mL of water and extracted three times with 10 
mL portions of methylene chloride. The organic extracts were washed with two 30 mL 
portions of brine followed by two 10 mL portions of saturated sodium bicarbonate 
solution. The organic extracts were dried with magnesium sulfate and condensed at 
reduced pressure. The crude product was then purified via column chromatography to 
give pure 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzo[d]imidazole (0.52g , 21% 
yield). The product was analyzed by GC-MS, and 1H NMR and 13C NMR 
spectroscopy. 
Rf-Value: Hexane/Ethyl acetate (30:70 v/v) = 0.33 
1H NMR (300 MHz, CDCl3) δ= 7.82 (s, 1H), 7.55 (s, 1H), 7.37 (s, 1H), 7.19 (s, 1H), 
6.34-6.30 (m, 2H), 5.24 (s, 2H), 2.38 (s, 3H), 2.36 (s, 3H) 
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13C NMR (75 MHz, CDCl3) δ= 148.80, 143.04, 142.39, 142.08, 132.27, 132.22, 
131.16, 120.35, 110.59, 109.84, 108.84, 41.67, 20.63, 20.25 
 
LRMS EI (m/z): [M+] calc’d for C14H14N2O 226.1, observed 226.1 
 
 
 
 
 
 
 
 
 80 
 
 
 Spectrum 19- 1H NMR of 1-((furan-3-yl)methyl)-5,6-dimethyl-1H-benzimidazole 
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Spectrum 20- 13C NMR of 1-((furan-2-yl)methyl)-5,6-dimethyl-1H-benzimidazole 
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Synthesis of 1-(3-(trifluoromethyl)benzyl)-5,6-dimethyl-1H-benzo[d]imidazole  
 
 
Under an inert nitrogen atmosphere, 5,6-dimethylbenzimidazole (1.0 g, 6.8 mmol) was 
added to a solution of potassium hydroxide (0.58 g, 10.3 mmol) in 20 mL of DMF and 
magnetically stirred for 30 minutes at room temperature. The mixture was cooled to 0 
˚C and 3-trifluoromethyl benzyl chloride (1.16 mL, 7.52 mmol) was added. The 
mixture was then left to warm to room temperature and monitored by TLC. After the 
reaction was complete, it was quenched with 30 mL of water and extracted three times 
with 20 mL portions of ethyl acetate. The organic extracts were washed with 20 mL of 
DI water followed by two 20 mL portions of brine. The organic extracts were dried 
with magnesium sulfate and condensed at reduced pressure. The crude product was 
then purified via column chromatography to give pure 1-(3-(trifluoromethyl)benzyl)-
5,6-dimethyl-1H-benzo[d]imidazole (1.52 g, 73% yield). The product was analyzed 
by GC-MS, and 1H NMR and 13C NMR spectroscopy.  
 
Rf-Value: Hexane/Ethyl acetate (10:90 v/v) = 0.33 
1H NMR (300 MHz, CDCl3) δ= 7.84 (s, 1H), 7.60 (s, 1H), 7.56 (d, J= 7.7 Hz), 7.49 
(s, 1H), 7.42 (t, J= 7.7, 1H), 7.24 (d, J=7.7 Hz, 1H), 7.00 (s, 1H), 5.34 (s, 2H), 2.36 (s, 
3H), 2.32 (s, 3H) 
 
13C NMR (75 MHz, CDCl3), 19F not decoupled δ= 142.60, 142.35, 136.97, 132.64, 
132.26, 131.49, 130.07, 129.66, 126.98, 125.60, 125.07 (q, JC-F= 3.9 Hz), 123.67 (q, 
JC-F= 3.9 Hz), 121.99, 120.55, 109.86, 48.13, 20.59 
  
LRMS EI (m/z): [M+] calc’d for C17H15F3N2 304.1, observed 304.1 	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  Spectrum 21- 1H NMR of 1-(3-(trifluoromethyl)benzyl)-5,6-dimethyl-1H-benzimidazole	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